Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering TherapiesApril 13th 2021
Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.
2 Clarke Drive
Cranbury, NJ 08512